Coventry Health Care signs definitive agreement to acquire Preferred Health Systems

NewsGuard 100/100 Score

Coventry Health Care, Inc. (NYSE: CVH) announced today that it has signed a definitive agreement to acquire Preferred Health Systems, Inc. (“PHS”), a wholly-owned subsidiary of Via Christi Health System, Inc. PHS, based in Wichita, Kansas, is a commercial health plan serving more than 100,000 commercial group risk members and 20,000 commercial self-funded members. As part of the transaction, Coventry is entering into a long-term provider and customer relationship with Via Christi Health System and its affiliates.

“I am delighted to announce this transaction which greatly strengthens Coventry’s presence in the Kansas market,” said Allen F. Wise, chief executive officer of Coventry. “PHS has established itself as a strong local-based health plan with an excellent track record of serving employer groups in the Wichita area. This acquisition reaffirms Coventry’s commitment to strengthening its health plan footprint and is consistent with our focus on our seven core businesses. Upon completion of this transaction, we will serve more than 1 million members in our six state Midwest region.”

The transaction is expected to close in the next 90 to 120 days subject to closing conditions and regulatory and other customary approvals. The transaction is expected to be neutral to earnings in the first year after closing. Financial terms of the transaction were not disclosed.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Evidence from Malawi: Typhoid conjugate vaccine provides protection for up to four years